Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner.
about
Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic TestingA review of the past, present, and future directions of neoplasiaNeoplasia: Where We Have Been and Where We Are GoingTransient reduction of placental angiogenesis in PAI-1-deficient miceTumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.Polymorphic variation of genes in the fibrinolytic system and the risk of ovarian cancer.Does plasminogen activator inhibitor-1 drive lymphangiogenesis?PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma.SFRP1 reduction results in an increased sensitivity to TGF-β signaling.Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells.Bone marrow mesenchymal stem cells are abnormal in multiple myeloma.Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study.Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expressionPAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes.SERPINE1 expression discriminates site-specific metastasis in human melanomaPlasminogen activator inhibitor 1 protects fibrosarcoma cells from etoposide-induced apoptosis through activation of the PI3K/Akt cell survival pathway.TGF-beta1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1.TGF-beta1-Induced Expression of the Poor Prognosis SERPINE1/PAI-1 Gene Requires EGFR Signaling: A New Target for Anti-EGFR Therapy.Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors.Neoplasia: An Anniversary of Progress.MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib.The proteolytic activity of MT4-MMP is required for its pro-angiogenic and pro-metastatic promoting effects.Effects of a High-Fat or High-Sucrose Diet on Ultraviolet B Irradiation-Induced Carcinogenesis and Tumor Growth in Melanin-Possessing Hairless Mice.
P2860
Q26801060-92E5AF40-851A-4840-9521-B1E910B64856Q28389391-84102918-664E-4AE8-B57D-730D7B17EC58Q28395095-FDE17978-66CE-4CA0-8113-6C4E794B0F49Q28510418-E5B30AA7-4EFB-48CE-BFC0-CA1C7D8D752BQ33295022-67322391-5ADD-4B3C-B985-B8F6883675B3Q33467391-17EC4DC0-B921-4941-9A15-40CB6DC23274Q33543002-00DE63D6-56C8-4F5C-A168-3B463F8D3A02Q33693105-00F74DDE-01DD-47FA-8BD3-74F7666B902AQ33814892-7200E1D5-8FEF-4070-9205-80A2BF940414Q34887726-BC3FF9E5-CDF2-4B87-830F-EBC8419EFC8FQ36311530-F12D3B99-FC8E-4E8C-96C7-2A9F468F3BF2Q36593549-B705EFF4-5B70-4C9D-8EF2-03D6150972A0Q36640228-D14DC1C9-2C4F-45F5-92D2-95A5FE9938C1Q37317112-A8820C71-8C99-46D8-B477-009E9CC34948Q37318149-A54953D0-F633-4F0E-94ED-56D08CDAD94FQ39709591-0E198020-2950-4E1F-83D1-E390879EC637Q42049845-D5CFA6CE-16E0-4847-9382-AC4BEBA4EFB6Q42136467-168E226E-DA21-404F-BF4C-3F9E715E10A0Q42399810-D948F7BA-CBE3-4518-B9B7-E67ACB5BA622Q43146931-12CAF1E6-F212-4993-B062-2391747CC830Q46407013-9C7AA871-C6A9-4992-BAAE-18C8AEBC33F8Q46932476-D237D0EA-C305-4639-BDB4-DD9B67348405Q50455931-BA210ACD-E22C-4844-8F73-F043B42B7B49Q51823101-471485B4-E697-427E-97E5-72D7B69E22CAQ52876816-D0EAA8F7-8907-45BE-943A-ED82A5DE3F82
P2860
Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Host plasminogen activator inh ...... n in a stage-dependent manner.
@ast
Host plasminogen activator inh ...... n in a stage-dependent manner.
@en
Host plasminogen activator inh ...... n in a stage-dependent manner.
@nl
type
label
Host plasminogen activator inh ...... n in a stage-dependent manner.
@ast
Host plasminogen activator inh ...... n in a stage-dependent manner.
@en
Host plasminogen activator inh ...... n in a stage-dependent manner.
@nl
prefLabel
Host plasminogen activator inh ...... n in a stage-dependent manner.
@ast
Host plasminogen activator inh ...... n in a stage-dependent manner.
@en
Host plasminogen activator inh ...... n in a stage-dependent manner.
@nl
P2093
P2860
P356
P1433
P1476
Host plasminogen activator inh ...... on in a stage-dependent manner
@en
P2093
Annabelle Lejeune
Carine Munaut
Catherine Maillard
Jean Michel Foidart
Laurence Melen
Maria Unni Rømer
Nils Brunner
Norbert E Fusenig
P2860
P356
10.1593/NEO.04406
P577
2005-01-01T00:00:00Z